yeast like fungal infections in medical intensive care unit in poland
DESCRIPTION
Presentation for The International Congress of Young medical Scientist in Poznań.TRANSCRIPT
![Page 1: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/1.jpg)
Wojciech Francuzik
Aleksandra Skłodowska Tutor: Prof. Zygmunt Adamski
Dermatology Interest Group, Student Scientific Society of Poznan University of Medical Sciences
![Page 2: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/2.jpg)
EPIDEMIOLOGY
TIME
GEOGRAPHICAL REGION
RESISTANCE TO ANTIMYCOTICS
![Page 3: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/3.jpg)
Examination of
medical
histories of ICU
patients with
fungal infections
Database
creation based
on mycological
diagnosis
Exclusion of
non-Candida
species
![Page 4: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/4.jpg)
Div
isio
n into
gro
ups C. albicans
C. glabrata
C. Tropicalis
C. krusei
Mixed group
![Page 5: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/5.jpg)
1) mycological diagnosis given by the mycology lab based on samples acquired in the medical ICU,
2) patient age and gender,
3) medical procedures that the patient underwent,
4) comorbid conditions that the patient suffered from.
![Page 6: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/6.jpg)
1. What were the most common pathogenic factors?
2. Did the occurence differed in various age groups?
3. Did diferent species were related to different comorbid conditions
4. Did infection corellated with higher death risk? And for what comorbid conditions.
![Page 7: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/7.jpg)
0
10
20
30
40
50
60
70
80
Our Study
1996-2000
![Page 8: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/8.jpg)
Histogram of patients’ age
Age
![Page 9: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/9.jpg)
0
10
20
30
40
50
60
70
80
90
18 – 39 40 – 59 60 – 79 80 +
C. albicans [N (%)]
C. glabrata [N (%)]
C. tropicalis [N (%)]
C. krusei [N (%)]
Mixed
![Page 10: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/10.jpg)
0
10
20
30
40
50
60
70
80
90
Diabetes
mellitus
Renal
insufficiency
Cirrhosis Renal
replacement
therapy
C. albicans
C. glabrata
C. tropicalis
C. krusei
mixed group
![Page 11: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/11.jpg)
Factor p value/
Age above 80 years 0.0011
Male gender 0.0070
Renal insufficiency 0.0120
Diabetes mellitus 0.0203
Hepatic insufficiency 0.0053
Renal replacement therapy 0.0388
![Page 12: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/12.jpg)
![Page 13: Yeast like fungal infections in medical intensive care unit in Poland](https://reader034.vdocuments.us/reader034/viewer/2022052523/5560b183d8b42a033c8b4641/html5/thumbnails/13.jpg)
C. glabrata increases in numbers and is linked to diabetes
Emergence of previously uncommon species
C. krusei and concomitant diseases
Fatal therapy outcomes
Drug susceptibility (AST)
Fluconazole prophylaxis